RU2227035C1 - Composition for prophylaxis and treatment of fibrocystic mastopathy - Google Patents

Abstract

FIELD: medicine, pharmacy. SUBSTANCE: invention relates a composition used for prophylaxis and treatment of fibrocystic mastopathy. The composition comprises anions HCO $\genfrac{}{}{0ex}{}{\text{-}}{\text{3}}$ , SO $\genfrac{}{}{0ex}{}{\text{2-}}{\text{4}}$ , Cl^-, Br^- and cations Ca²⁺, Mg²⁺, (Na⁺+K⁺) and water taken in the definite amounts. Invention provides the enhancement effectiveness for prophylaxis and treatment of mastopathy, elimination of allergic responses and other adverse effects. EFFECT: valuable medicinal properties of composition. 6 ex

Description

The invention relates to medicine, to means of prophylaxis and treatment of fibrocystic mastopathy.

Known composition "Mastodinone" for the prevention and treatment of fibrocystic mastopathy, containing active substances and a solvent (Vidal Handbook. Medicines of Russia. M., Astra Farm Severvis, 1999, with B-380).

This known composition is a homeopathic medicine of foreign manufacture. It includes active substances in the form of a set of six plant components and the solvent is a water-alcohol liquid. The composition is applied inside in the form of drops.

However, the components that make up this known composition are difficult to access and expensive. The preparation technology of this known composition is complex and includes the preliminary preparation of each of the six plant components and the subsequent preparation of their infusions. The use of a known composition for medicinal purposes is recommended for at least six weeks. For the purpose of prevention, the composition should be used with great caution due to possible adverse reactions. For example, a number of patients have allergic reactions in response to taking this composition. The composition is not recommended for patients prone to a painful craving for alcohol.

The technical result achieved by the implementation of the present invention is to simplify, increase the effectiveness of the prevention and treatment of mastopathy, exclude allergic reactions and other side effects, use the available components that make up the means for the prevention and treatment of fibrocystic mastopathy, provide the possibility of unlimited use in preventive purposes.

The specified technical result is achieved in that the composition for the prevention and treatment of fibrocystic mastopathy, containing active ingredients and a solvent, has the distinctive feature that it contains anions of NSO as active substances $\genfrac{}{}{0ex}{}{\text{-}}{\text{3}}$ SO $\genfrac{}{}{0ex}{}{\text{2-}}{\text{4}}$ , Cl ^- , Br ^- and cations Ca ²⁺ , Mg ²⁺ , (Na ⁺ + K ⁺ ), as a solvent - water in the following ratio of components, mg / dm ³ :

NSO $\genfrac{}{}{0ex}{}{\text{-}}{\text{3}}$ 250-450

SO $\genfrac{}{}{0ex}{}{\text{2-}}{\text{4}}$ Less than 150

Cl ^- 700-1700

Br ^- 5-25

Ca ²⁺ Less than 100

Mg ²⁺ 200-500

(Na ⁺ + K ⁺ ) 100-400

Water Else

In the course of work with patients suffering from fibrocystic mastopathy, a positive effect on the treatment process of a set of anions and cations taken in a certain qualitative and quantitative ratio was unexpectedly established. These anions and cations are necessary not only for treatment, but also for the prevention of fibrocystic mastopathy.

The composition is easy to manufacture. It can be prepared by diluting the natural bischofite mineral with natural or reconstituted drinking water.

The natural mineral bischofite is a magnesium chloride produced in the form of brine in the Narimanov section of the Volgograd field. It is an oily liquid with a total salinity of 415-460 g / l. The density of bischofite is 1.3-1.32 g / cm ³ , pH 4.5-4.7. Bischofite contains magnesium chloride - up to 434.5 g / l, magnesium bromide - 4-9 g / l, calcium sulfate - up to 1 g / l, calcium hydrogen carbonate - 0.5 g / l, potassium chloride - up to 5 g / l , sodium chloride up to 5 g / l, calcium chloride up to 5 g / l. To prepare the product according to the invention, bischofite is diluted with drinking water until the total mineralization of the prepared solution is 1.2-2.8 g / dm ³ . In this case, mineral water is obtained. Taking into account the value of the level of its total mineralization and mainly magnesium cationic composition, it is medicinal-table water and occupies an intermediate position among the known, industrially bottled mineral waters of the sixteenth, twentieth and twenty-seventh groups (GOST 13273-88).

The following are examples illustrating the invention.

Example 1. By diluting the natural mineral bischofite with natural drinking water until a total mineralization of the resulting solution of 1.2 g / dm ^{3 is} achieved, a composition is prepared which has the following ratio of components, mg / dm ³ , i.e. mg per 1000 ml:

NSO $\genfrac{}{}{0ex}{}{\text{-}}{\text{3}}$ 250

SO $\genfrac{}{}{0ex}{}{\text{2-}}{\text{4}}$ 75

Cl ^- 700

Br ^- 5

Ca ²⁺ 75

Mg ²⁺ 200

(Na ⁺ + K ⁺ ) 100

Water Else

Example 2. The natural mineral bischofite was diluted with reconstituted drinking water until the total mineralization of the prepared solution was 2.8 g / dm ³ . The composition had the following ratio of components, mg / dm ³ , i.e. mg per 1000 ml:

NSO $\genfrac{}{}{0ex}{}{\text{-}}{\text{3}}$ 450

S0 $\genfrac{}{}{0ex}{}{\text{2-}}{\text{4}}$ 140

Cl ^- 700

Br ^- 25

Ca ²⁺ 90

Mg ²⁺ 500

(Na ⁺ + K ⁺ ) 400

Water Else

Example 3. A group of women from 22 people with a diagnosis of fibrocystic mastopathy with pain for oral administration was prescribed a composition prepared by diluting the natural mineral bischofite with natural drinking water until the total mineralization of the prepared solution 1.2 g / dm ³ (composition according to example 1 )

Patients took the composition in the amount ^of _1/2 cup in three divided doses 30 minutes before meals for 30 days. The temperature of the composition is 37-40 ° C.

Subjectively, all patients after completion of the course of treatment noted a decrease in pain. Objectively, the course of treatment ended with a decrease in turgor of breast tissue. Allergic reactions to the composition are not fixed.

Example 4. 45 women with a diagnosis of fibrocystic mastopathy with pain were prescribed an oral composition prepared by diluting the natural mineral bischofite with reconstituted drinking water to achieve a total mineralization of the prepared solution of 2.8 g / dm ³ (composition according to example 2).

Patients took the composition in the amount ^of _1/2 cup in three divided doses 60 minutes before meals for 24 days. The temperature of the composition is 37-40 ° C.

After completion of the course of treatment, all patients noted a decrease in pain. All patients showed a decrease in turgor of breast tissue. None of the women who underwent a course of treatment had any allergic reactions to the composition used for their treatment. Patients enjoyed the composition with pleasure, they developed a daily habit of taking it before meals.

Example 5. The composition according to example 1 was prescribed to women who were resting for the entire period of their stay in the sanatorium. Vacationers with pleasure took the composition before meals, noted its positive effect on the digestion process. Before arriving at the sanatorium, a number of women had subjective unpleasant mild painful sensations in the mammary glands. After completing the course of spa treatment, these women no longer showed painful symptoms. No side effects were noted. Women were recommended to take the composition for prophylactic purposes in the future.

Example 6. Women undergoing spa treatment regularly before meals took the composition of example 2 during the entire course of spa treatment. Those of them that previously felt a mild painful symptom on the part of the mammary glands noted the cessation of painful sensations after 1-1.5 weeks of taking the new composition. At the same time, all women noted an improvement in the digestive tract. No adverse reactions, including allergic reactions, were noted. Reception of the composition became a pleasant habit. Women were encouraged to continue taking the composition as a preventive measure.

The new composition is an aqueous solution of minerals - mineral water prepared from the natural mineral bischofite. It is advisable to recommend the composition for regular use as a preventive measure. He was given the name “Aqua-Bi”.

Thus, an accessible composition is recommended, which allows you to quickly (in 24-30 days) successfully treat fibrocystic mastopathy with pain, reduce pain, and reduce breast turgor. The composition can be regularly used for preventive purposes.

Claims (1)

Composition for the prevention and treatment of fibrocystic mastopathy, containing active ingredients and a solvent, characterized in that it contains anions of NSO as active substances $\genfrac{}{}{0ex}{}{\text{-}}{\text{3}}$ SO $\genfrac{}{}{0ex}{}{\text{2-}}{\text{4}}$ , Cl ^- , Br ^- and cations Ca ²⁺ Mg ²⁺ , (Na ⁺ + K ⁺⁾ , as a solvent - water in the following ratio of components, mg / dm: NSO $\genfrac{}{}{0ex}{}{\text{-}}{\text{3}}$ 250-450 SO $\genfrac{}{}{0ex}{}{\text{2-}}{\text{4}}$ 75-150 Cl ^- 700-1700 Br ^- 5-25 Ca ²⁺ 75-100 Mg ²⁺ 200-500 (Na ⁺ + K ⁺ ) 100-400 Water Else